PharmID was founded in early 2017 to develop and commercialize technology developed by MarqMetrix for healthcare and pharmacy uses. MarqMetrix has been providing non-destructive quantitative and qualitative Raman Spectroscopy tools and services to industrial clients (petro- and agri-chemical, pharmaceutical and others) for the last 5+ years. Two of the founders of PharmID have family connections in pharmacy, so it was only a matter of time before the connection of Raman Spectroscopy to assist pharmacy in identification and verification of medications was made. PharmID is currently pursuing products to support drug diversion prevention, IV compounding verification and other activities where knowing for certain what-the-drug-is is important.

PharmID was founded in early 2017 to develop and commercialize technology developed by MarqMetrix for healthcare and pharmacy uses. MarqMetrix has been providing non-destructive quantitative and qualitative Raman Spectroscopy tools and services to industrial clients (petro- and agri-chemical, pharmaceutical and others) for the last 5+ years. Two of the founders of PharmID have family connections in pharmacy, so it was only a matter of time before the connection of Raman Spectroscopy to assist pharmacy in identification and verification of medications was made. PharmID is currently pursuing products to support drug diversion prevention, IV compounding verification and other activities where knowing for certain what-the-drug-is is important.

Our Expedio™ Hereditary Cancer and Inspexion™ Pharmacogenetics tests are physician-directed genetic screenings that offer a cost-effective strategy designed to achieve optimized, personalized care for your patients.